Live, Hands On Injection Training
Each physician who participates will be required to bring a patient. Attendees will be divided into small groups, and the injections will be overseen by the faculty. Product and medical supplies are included.
**In order to treat your patient, you must have a valid medical licence in the state where the program is taking place.
Learning Objectives
Upon completion of this CME program, participants should be able to:
- Perform an aesthetic evaluation utilizing a comprehensive approach to global beauty that takes into consideration each patient’s beauty potential as well as the impact of facial aging.
- Compare and contrast the characteristics of HA soft tissue fillers and identify their best uses in all areas of the face: upper, mid and lower.
- Identify injection techniques with HA soft tissue fillers that have demonstrated safe and satisfactory patient outcomes for facial enhancement and/or rejuvenation and learn how to implement them in clinical practice.
Target Audience
This activity is primarily intended and designed to educate dermatologists, facial plastic surgeons, otolaryngologists, ophthalmologists, oculoplastic surgeons, and plastic surgeons.
Accreditation
Physicians: This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education through the joint sponsorship of USF Health and Medical Education Advocates, LLC. USF Health is accredited by the ACCME to provide continuing medical education for physicians.
USF Health designates this activity for a maximum of 8.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity
Americans with Disabilities Act
Event staff will be glad to assist you with any special needs (ie, physical, dietary, etc). Please contact Tabetha Jordan prior to the live event at (866) 477-7153.
Unapproved Use Disclosure
USF Health requires CME faculty (speakers) to disclose to attendees when products or procedures being discussed are off-label, unlabeled, experimental, and/or investigational (not FDA approved); and any limitations on the information that is presented, such as data that are preliminary or that represent ongoing research, interim analyses, and/or unsupported opinion. Faculty may/will discuss information about pharmaceutical agents that is outside of U.S. Food and Drug Administration approved labeling. This information is intended solely for continuing medical education and is not intended to promote off-label use of these medications. If you have questions, contact the medical affairs department of the manufacturer for the most recent prescribing information.
